Protai

Proteomics Centered AI Powered Drug Discovery Platform

Active Seed Startup Tel Aviv-Yafo Founded 2021-07

Protai has built an end-to-end AI-based platform that comprehensively maps the course of disease on the protein level, enhancing the ability to observe cellular function and improve the way new drugs are discovered. The company is building machine learning models combining deep proteomics to identify up to 1 million proteoforms, including post-translational…

SectorHealth Tech & Life Sciences
StageSeed
Total raised$20.0M
Employees25
Founded2021-07
HQTel Aviv-Yafo
Patents1
Confidence90
Sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & Development
Technology
Artificial IntelligenceMachine LearningPlatforms & InterfacesSoftware
Target customers
Healthcare & Life SciencesLife SciencesPharmaceuticals